PARIS, Dec 10, 2020 / PRNewswire / – MicroPort Cardio Rhythm Management (CRM) has announced the first enrollment in the Astral-4LV [1] clinical trial to evaluate the safety and efficiency of Axone ™ , a revolutionary and innovative ventricular lead quadruple left. Axone ™ is designed for use in heart failure patients with indications for cardiac resynchronization therapy […]